These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2378830)

  • 21. [Maternal lipoproteins post partum. Qualitative and quantitative studies of the effect of lactation].
    Brockerhoff P; Stinner B; Holzer A; Friese K; Schicketanz KH; Rathgen GH
    Gynakol Rundsch; 1989; 29(1):12-21. PubMed ID: 2722070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of puerperal lactation using jasmine flowers (Jasminum sambac).
    Shrivastav P; George K; Balasubramaniam N; Jasper MP; Thomas M; Kanagasabhapathy AS
    Aust N Z J Obstet Gynaecol; 1988 Feb; 28(1):68-71. PubMed ID: 3214386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bromocriptine and methergoline in the inhibition of puerperal lactation].
    Abate F; Oliva A; Baviera G; La Spada R; Leonardi R; Bellinvia G
    Minerva Ginecol; 1984 Jun; 36(6):303-6. PubMed ID: 6472723
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of puerperal lactation with 2-mercaptopropionyl-glycine.
    Akrivis C; Vezyraki P; Kiortsis DN; Fotopoulos A; Evangelou A
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):621-3. PubMed ID: 11214766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of lactation comparing stilboestrol and bromocriptine (CB154).
    Ladipo OA; Ojo OA
    Niger Med J; 1979 Jan; 9(1):77-9. PubMed ID: 463344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of puerperal lactation with Parlodel long-acting (Parlodel LA).
    Rolland R; Nijdam W; Weyer A; Lancranjan I
    Eur J Obstet Gynecol Reprod Biol; 1986 Sep; 22(5-6):337-43. PubMed ID: 3770284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
    Giorda G; de Vincentiis S; Motta T; Casazza S; Fadin M; D'Alberton A
    Gynecol Obstet Invest; 1991; 31(2):93-6. PubMed ID: 2037265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Puerperal lactation suppression and prolactin.
    De Gezelle H; Dhont M; Thiery M; Parewyck W
    Acta Obstet Gynecol Scand; 1979; 58(5):469-72. PubMed ID: 394563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal spray vs oral administration of bromocriptine: pharmacology and effect on serum prolactin in puerperal women.
    Cicinelli E; Cignarelli M; Petruzzi D; Matteo MG; Ruccia C; Schonauer LM
    J Endocrinol Invest; 1996; 19(7):427-32. PubMed ID: 8884536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of the suppression of lactation and the influence on blood clotting with bromocriptine (CB 154) (Parlodel): a double blind comparison with diethylstilboestrol.
    Nilsen PA; Meling AB; Abildgaard U
    Acta Obstet Gynecol Scand; 1976; 55(1):39-44. PubMed ID: 766555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effects of bromocriptine on mammary development and function in lactating mice.
    Knight CH; Calvert DT; Flint DJ
    J Endocrinol; 1986 Aug; 110(2):263-70. PubMed ID: 3746163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nasal spray administration of bromocriptine: pharmacology and effect on serum prolactin level in puerperal women.
    Cicinelli E; Cignarelli M; Petruzzi D; Matteo G; Ruccia C; Schonauer LM
    Gynecol Endocrinol; 1996 Dec; 10(6):391-6. PubMed ID: 9032565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression by bromocriptine of the serum lactalbumin peak associated with human lactogenesis.
    Martin RH; Glass MR; Chapman C; Wilson GD; Woods KL
    Clin Endocrinol (Oxf); 1981 Apr; 14(4):363-6. PubMed ID: 7261418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience relating to pregnancy, lactation, and the after-weaning condition of hyperprolactinemic patients treated with bromocriptine.
    Godó G; Koloszár S; Szilágyi I; Daru J; Sas M
    Fertil Steril; 1989 Mar; 51(3):529-31. PubMed ID: 2920853
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of bromocriptine versus breast binders as inhibitors of postpartum lactation.
    Shapiro AG; Thomas L
    South Med J; 1984 Jun; 77(6):719-21. PubMed ID: 6729548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptine.
    Montini M; Pagani G; Gianola D; Pagani MD; Salmoiraghi M; Ferrari L; Lancranjan I
    J Clin Endocrinol Metab; 1986 Jul; 63(1):266-8. PubMed ID: 3711262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.
    Webster J
    Drug Saf; 1996 Apr; 14(4):228-38. PubMed ID: 8713691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bromocriptine mesylate for prevention of postpartum lactation.
    Duchesne C; Leke R
    Obstet Gynecol; 1981 Apr; 57(4):464-7. PubMed ID: 7243095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metergoline as a lactation inhibitor.
    Caballero A; Palomo A; Molina CE; Albarrán FJ; Caballero A; Mena P
    J Reprod Med; 1982 Apr; 27(4):202-6. PubMed ID: 7097670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.